{"id":99888,"date":"2023-05-12T12:48:56","date_gmt":"2023-05-12T12:48:56","guid":{"rendered":"http:\/\/lebanonnewsgazette.com\/?guid=e131aa3cdb90155f6ca1867c61cc1a1d"},"modified":"2023-05-12T12:48:56","modified_gmt":"2023-05-12T12:48:56","slug":"uae-biotech-insilico-medicine-offers-disease-modeling-and-target-identification-course-using-ai","status":"publish","type":"post","link":"https:\/\/lebanonnewsgazette.com\/uae-biotech-insilico-medicine-offers-disease-modeling-and-target-identification-course-using-ai\/","title":{"rendered":"UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI"},"content":{"rendered":"
\n

Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that it is releasing a course on Disease Modeling and Target Identification<\/a>, available for free. Through seven lectures, the course guides participants through the latest insights in disease modeling and target discovery \u2013 critical areas in biomedical research that involve using computational and experimental approaches to gain insights into the causes of diseases and identify potential targets for drug development.<\/p>\n

The course uses case studies to illustrate the practical application of the concepts covered. In particular, learners will have the opportunity to explore a demo version of PandaOmics, Insilico Medicine\u2019s generative AI tool for target discovery, which is being developed by a team of scientists at the Insilico Medicine Generative Artificial Intelligence and Quantum Computing Research and Development Center in Abu Dhabi, the region\u2019s largest AI-powered biotechnology research center.<\/p>\n

PandaOmics is used by numerous pharmaceutical companies and to develop the 31 pharmaceutical assets advancing in Insilico\u2019s own pipeline \u2013 including two drugs for idiopathic pulmonary fibrosis and COVID-19 currently in clinical trials.<\/p>\n

After completing the course, participants will gain:\u00a0 .<\/p>\n